New Treatment for Acute Myeloid Leukemia
November 25, 2025
November 25, 2025
CHARLOTTESVILLE, Virginia, Nov. 25 -- University of Virginia Health posted the following news release:
* * *
New Treatment for Acute Myeloid Leukemia
*
Biomedical research that began at the School of Medicine has yielded a much-needed new treatment for patients with the deadliest blood cancer, acute myeloid leukemia.
The federal Food and Drug Administration has approved the drug ziftomenib for patients with recurring or treatment- . . .
* * *
New Treatment for Acute Myeloid Leukemia
*
Biomedical research that began at the School of Medicine has yielded a much-needed new treatment for patients with the deadliest blood cancer, acute myeloid leukemia.
The federal Food and Drug Administration has approved the drug ziftomenib for patients with recurring or treatment- . . .